181 related articles for article (PubMed ID: 30208282)
1. Surviving in the Valley of Death: Opportunities and Challenges in Translating Academic Drug Discoveries.
Parrish MC; Tan YJ; Grimes KV; Mochly-Rosen D
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():405-421. PubMed ID: 30208282
[TBL] [Abstract][Full Text] [Related]
2. Collaborative pre-competitive preclinical drug discovery with academics and pharma/biotech partners at Sanford|Burnham: infrastructure, capabilities & operational models.
Chung TD
Comb Chem High Throughput Screen; 2014 Mar; 17(3):272-89. PubMed ID: 24409951
[TBL] [Abstract][Full Text] [Related]
3. Translational research: the changing landscape of drug discovery.
Fishburn CS
Drug Discov Today; 2013 May; 18(9-10):487-94. PubMed ID: 23247258
[TBL] [Abstract][Full Text] [Related]
4. National Heart, Lung, and Blood Institute and the translation of cardiovascular discoveries into therapeutic approaches.
Galis ZS; Black JB; Skarlatos SI
Circ Res; 2013 Apr; 112(9):1212-8. PubMed ID: 23620235
[TBL] [Abstract][Full Text] [Related]
5. Perspectives in regulatory science: translational and clinical pharmacology.
Grillo JA; Huang SM
Drug Discov Today Technol; 2016; 21-22():67-73. PubMed ID: 27978990
[TBL] [Abstract][Full Text] [Related]
6. Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective.
Wong EH; Yocca F; Smith MA; Lee CM
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1269-84. PubMed ID: 20716397
[TBL] [Abstract][Full Text] [Related]
7. Re-engineering drug discovery and development.
FitzGerald GA
LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
[TBL] [Abstract][Full Text] [Related]
8. The path from bench to bedside: considerations before starting the journey.
Freeman MW; Dervan AP
J Investig Med; 2011 Jun; 59(5):746-51. PubMed ID: 21441830
[TBL] [Abstract][Full Text] [Related]
9. Academic-industry Collaborations in Translational Stroke Research.
Boltze J; Wagner DC; Barthel H; Gounis MJ
Transl Stroke Res; 2016 Aug; 7(4):343-53. PubMed ID: 27301976
[TBL] [Abstract][Full Text] [Related]
10. Bridging the translational gap: collaborative drug development and dispelling the stigma of commercialization.
Yu HW
Drug Discov Today; 2016 Feb; 21(2):299-305. PubMed ID: 26546858
[TBL] [Abstract][Full Text] [Related]
11. Academic-Pharma drug discovery alliances: seeking ways to eliminate the valley of death.
Hammonds T
Future Med Chem; 2015; 7(14):1891-9. PubMed ID: 26393391
[TBL] [Abstract][Full Text] [Related]
12. Successfully navigating the valley of death: the importance of accelerators to support academic drug discovery and development.
Everts M; Drew M
Expert Opin Drug Discov; 2024 Feb; 19(2):253-258. PubMed ID: 37968916
[TBL] [Abstract][Full Text] [Related]
13. The SULSA Assay Development Fund: accelerating translation of new biology from academia to pharma.
McElroy SP; Jones PS; Barrault DV
Drug Discov Today; 2017 Feb; 22(2):199-203. PubMed ID: 27720829
[TBL] [Abstract][Full Text] [Related]
14. The Current Status of Drug Discovery and Development as Originated in United States Academia: The Influence of Industrial and Academic Collaboration on Drug Discovery and Development.
Takebe T; Imai R; Ono S
Clin Transl Sci; 2018 Nov; 11(6):597-606. PubMed ID: 29940695
[TBL] [Abstract][Full Text] [Related]
15. Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.
Povsic TJ; Scott R; Mahaffey KW; Blaustein R; Edelberg JM; Lefkowitz MP; Solomon SD; Fox JC; Healy KE; Khakoo AY; Losordo DW; Malik FI; Monia BP; Montgomery RL; Riesmeyer J; Schwartz GG; Zelenkofske SL; Wu JC; Wasserman SM; Roe MT
Cardiovasc Drugs Ther; 2017 Aug; 31(4):445-458. PubMed ID: 28735360
[TBL] [Abstract][Full Text] [Related]
16. The changing roles of industry and academia.
Bauer EA; Cohen DE
J Invest Dermatol; 2012 Mar; 132(3 Pt 2):1033-6. PubMed ID: 22330271
[TBL] [Abstract][Full Text] [Related]
17. Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise.
Waldman SA; Terzic A
Clin Transl Sci; 2011 Feb; 4(1):69-71. PubMed ID: 21348959
[No Abstract] [Full Text] [Related]
18. Successfully accelerating translational research at an academic medical center: the University of Michigan-Coulter translational research partnership program.
Pienta KJ
Clin Transl Sci; 2010 Dec; 3(6):316-8. PubMed ID: 21167009
[TBL] [Abstract][Full Text] [Related]
19. Role of Academic Drug Discovery in the Quest for New CNS Therapeutics.
Yokley BH; Hartman M; Slusher BS
ACS Chem Neurosci; 2017 Mar; 8(3):429-431. PubMed ID: 28195461
[TBL] [Abstract][Full Text] [Related]
20. Drug discovery market exclusivity after KSR: the challenge to pharmaceutical scientists and the US congress.
Wolff ME
J Pharm Sci; 2011 Aug; 100(8):3044-3054. PubMed ID: 21472728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
